An historic milestone for the kidney community! As of October 1, 2025, U.S. healthcare providers can document a patient’s AMKD diagnosis, paving the way for enhanced patient care, public health data and research opportunities for this genetic form of chronic kidney disease.
Hear Emani McConnell-Brent's story with APOL1-mediated kidney disease (AMKD) and how she’s used her diagnosis to inspire and educate others on the importance of being an active participant in their own health.
Hear Sharron Rouse’s first-hand experience living with APOL1-mediated kidney disease (AMKD); how it prompted her to be an active participant in her own health and how her family supported her — emotionally and physically — in her journey.
Vice President of Clinical Development Dr. Ogo Egbuna shares why it’s important to raise awareness about APOL1-mediated kidney disease (AMKD).